SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention
- PMID: 33301245
- PMCID: PMC7745179
- DOI: 10.1056/NEJMe2034717
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention
Comment on
-
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10. N Engl J Med. 2020. PMID: 33301246 Free PMC article. Clinical Trial.
Similar articles
-
Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [ComirnatyⓇ]).Int J Infect Dis. 2022 Nov;124:187-189. doi: 10.1016/j.ijid.2022.09.019. Epub 2022 Sep 16. Int J Infect Dis. 2022. PMID: 36122668 Free PMC article.
-
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236. JAMA Netw Open. 2022. PMID: 35960521 Free PMC article.
-
US authorization of first COVID vaccine marks new phase in safety monitoring.Nature. 2020 Dec;588(7838):377-378. doi: 10.1038/d41586-020-03542-4. Nature. 2020. PMID: 33311629 No abstract available.
-
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.Front Public Health. 2021 Nov 23;9:778964. doi: 10.3389/fpubh.2021.778964. eCollection 2021. Front Public Health. 2021. PMID: 34888290 Free PMC article. Review.
-
Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.J Pharm Pract. 2022 Dec;35(6):947-951. doi: 10.1177/08971900211009650. Epub 2021 Apr 12. J Pharm Pract. 2022. PMID: 33840294 Review.
Cited by
-
Longitudinal evaluation of two different COVID-19 vaccination strategies in individuals with and without previous SARS-CoV-2 infection.Infez Med. 2023 Dec 1;31(4):509-516. doi: 10.53854/liim-3104-10. eCollection 2023. Infez Med. 2023. PMID: 38075426 Free PMC article.
-
The "Criminal Shield": Criminal Liability for Healthcare Professionals during the COVID-19 Pandemic.Healthcare (Basel). 2023 Oct 1;11(19):2661. doi: 10.3390/healthcare11192661. Healthcare (Basel). 2023. PMID: 37830698 Free PMC article.
-
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.Viruses. 2023 Jul 30;15(8):1659. doi: 10.3390/v15081659. Viruses. 2023. PMID: 37632002 Free PMC article.
-
Self-reported symptoms after COVID-19 vaccination. Distinct sex, age, and geographical outcomes in Lebanese and Italian cohorts.Intern Emerg Med. 2023 Aug;18(5):1463-1475. doi: 10.1007/s11739-023-03321-9. Epub 2023 Jun 15. Intern Emerg Med. 2023. PMID: 37322183 Free PMC article.
-
A free boundary problem-in time-for the spread of Covid-19.J Math Biol. 2023 Feb 15;86(3):45. doi: 10.1007/s00285-023-01881-0. J Math Biol. 2023. PMID: 36790624 Free PMC article.
References
-
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 Covid-19 vaccine. N Engl J Med. DOI: 10.1056/NEJMoa2034577. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous